Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer.
Westdorp H, Creemers JHA, van Oort IM, Schreibelt G, Gorris MAJ, Mehra N, Simons M, de Goede AL, van Rossum MM, Croockewit AJ, Figdor CG, Witjes JA, Aarntzen EHJG, Mus RDM, Brüning M, Petry K, Gotthardt M, Barentsz JO, de Vries IJM, Gerritsen WR. Westdorp H, et al. Among authors: simons m. J Immunother Cancer. 2019 Nov 14;7(1):302. doi: 10.1186/s40425-019-0787-6. J Immunother Cancer. 2019. PMID: 31727154 Free PMC article. Clinical Trial.
Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome.
van Wilpe S, Sultan S, Gorris MAJ, Somford DM, Kusters-Vandevelde HVN, Koornstra RHT, Gerritsen WR, Simons M, van der Heijden AG, de Vries IJM, Mehra N. van Wilpe S, et al. Among authors: simons m. Cancer Immunol Immunother. 2023 Jan;72(1):137-149. doi: 10.1007/s00262-022-03234-0. Epub 2022 Jun 30. Cancer Immunol Immunother. 2023. PMID: 35771253 Free PMC article.
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand.
Derks YHW, Schilham MGM, Rijpkema M, Smeets EMM, Amatdjais-Groenen HIV, Kip A, van Lith SAM, van de Kamp J, Sedelaar JPM, Somford DM, Simons M, Laverman P, Gotthardt M, Löwik DWPM, Heskamp S, Lütje S. Derks YHW, et al. Among authors: simons m. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2872-2884. doi: 10.1007/s00259-023-06224-1. Epub 2023 Apr 15. Eur J Nucl Med Mol Imaging. 2023. PMID: 37060367 Free PMC article.
Tumoral Ki67 and PSMA Expression in Fresh Pre-PSMA-RLT Biopsies and Its Relation With PSMA-PET Imaging and Outcomes of PSMA-RLT in Patients With mCRPC.
Laarhuis BI, Janssen MJR, Simons M, van Kalmthout LWM, van der Doelen MJ, Peters SMB, Westdorp H, van Oort IM, Litjens G, Gotthardt M, Nagarajah J, Mehra N, Privé BM. Laarhuis BI, et al. Among authors: simons m. Clin Genitourin Cancer. 2023 Oct;21(5):e352-e361. doi: 10.1016/j.clgc.2023.04.003. Epub 2023 Apr 21. Clin Genitourin Cancer. 2023. PMID: 37164814 Free article.
Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype.
van Wilpe S, Simnica D, Slootbeek P, van Ee T, Pamidimarri Naga S, Gorris MAJ, van der Woude LL, Sultan S, Koornstra RHT, van Oort IM, Gerritsen WR, Kroeze LI, Simons M, van Leenders GJLH, Binder M, de Vries IJM, Mehra N. van Wilpe S, et al. Among authors: simons m. Oncoimmunology. 2022 Jul 1;11(1):2094133. doi: 10.1080/2162402X.2022.2094133. eCollection 2022. Oncoimmunology. 2022. PMID: 35800157 Free PMC article.
PD-L1 in gestational trophoblastic disease: an antibody evaluation.
Hoeijmakers YM, Simons M, Bulten J, Gorris MAJ, Ottevanger PB, de Vries IJM, Sweep FCGJ. Hoeijmakers YM, et al. Among authors: simons m. Acta Obstet Gynecol Scand. 2022 Sep;101(9):1007-1016. doi: 10.1111/aogs.14404. Epub 2022 Jun 11. Acta Obstet Gynecol Scand. 2022. PMID: 35689468 Free PMC article.
1,482 results